Understanding Alzheimer's: Scientists find new way to study disease

Nov 08, 2010

(PhysOrg.com) -- Scottish scientists have made an important breakthrough in understanding how Alzheimer’s disease takes hold of the brain.

The researchers at the University of St Andrews have found a new way of studying the enzyme that has been implicated in the development of the debilitating disease.

Supported by the Alzheimer’s Research Trust, the group hope to use their findings to design a drug that could potentially stop Alzheimer’s in its tracks.

The development has been described as 'an exciting step forward for dementia research' by the ART, the UK’s leading dementia research charity.

Funded by an £84,743 grant from the charity, St Andrews' PhD student Kirsty Muirhead has been collaborating with scientists across the globe in the new development that involves the use of a new fluorescent tracking chemical that reacts with the enzyme inside living cells.

The enzyme, known as amyloid-binding alcohol dehydrogenase (ABAD), normally helps the brain cells produce energy, but in people with Alzheimer’s disease, a toxic protein called amyloid binds onto the enzyme, stopping it from working properly.

Using the new chemical, the researchers have been able to see this process under the microscope for the first time.

Miss Muirhead, 25, said, “Our ultimate aim is to stop amyloid binding onto ABAD, which will allow the to do its job, but before we can do that, we have to be able to measure what is happening inside the cell. This is the first time it has been possible to see the interaction inside living cells.

“I chose to work on this project because I wanted to do something that was going to have a benefit for people, so I’m very excited about this progress.”

Her supervisor, Dr Frank Gunn-Moore, commented, “This work marks an important development for us, and has partly been made possible because scientists from different fields have come together to share their knowledge. Indeed this has been a team effort from ourselves here in St Andrews and Kirsty’s co-supervisor Dr Stuart Conway at the University of Oxford.

“We now hope to build on this success by finding a chemical that could stop amyloid and ABAD binding, which could in turn help us design an effective treatment for Alzheimer’s.”

The research is published online by the journal ACS Chemical Biology.

Explore further: Structure of sodium channels different than previously believed

Provided by University of St Andrews

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Exercise may reduce Alzheimer's disease brain changes

Oct 04, 2010

(PhysOrg.com) -- Walking, jogging and other forms of regular aerobic exercise may actually ward off the onset of Alzheimer’s disease pathology in the brain, suggests newly published research from Washington ...

Professor uses ultrasound to treat Alzheimer's

Oct 15, 2010

(PhysOrg.com) -- Biomedical engineer Elisa Konofagou and her team are on the brink of uncovering a new, potentially groundbreaking use for ultrasound: the ability to temporarily open up the natural barrier ...

Researchers target HIV-related brain difficulties

Oct 07, 2010

(PhysOrg.com) -- During the last two decades, scientists and doctors have developed a potent mix of medications that nearly stops HIV in its tracks for most patients. This combination antiretroviral therapy, or cART, can ...

Modern society made up of all types

Nov 04, 2010

Modern society has an intense interest in classifying people into ‘types’, according to a University of Melbourne Cultural Historian, leading to potentially catastrophic life-changing outcomes for those typed – ...

Recommended for you

Breakthrough points to new drugs from nature

Apr 16, 2014

Researchers at Griffith University's Eskitis Institute have developed a new technique for discovering natural compounds which could form the basis of novel therapeutic drugs.

World's first successful visualisation of key coenzyme

Apr 16, 2014

Japanese researchers have successfully developed the world's first imaging method for visualising the behaviour of nicotine-adenine dinucleotide derivative (NAD(P)H), a key coenzyme, inside cells. This feat ...

User comments : 0

More news stories

A sharp eye on Southern binary stars

Unlike our sun, with its retinue of orbiting planets, many stars in the sky orbit around a second star. These binary stars, with orbital periods ranging from days to centuries, have long been the primary ...